Get access

Emerging infectious disease agents and their potential threat to transfusion safety

Authors

  • Susan L. Stramer,

    1. From the Scientific Support Office, American Red Cross, Gaithersburg, Maryland; Eugene B. Casey Hepatitis Research Center, Baylor College of Medicine, Houston, Texas; Mississippi Valley Regional Blood Center, Davenport, Iowa; UBC School of Medicine, Victoria, BC, Canada; AABB, Bethesda, Maryland; Fenwal, Inc., Lake Zurich, Illinois; Regulatory Affairs, AABB, Bethesda, Maryland; and American Red Cross Holland Laboratory, Rockville, Maryland.
    Search for more papers by this author
  • F. Blaine Hollinger,

    1. From the Scientific Support Office, American Red Cross, Gaithersburg, Maryland; Eugene B. Casey Hepatitis Research Center, Baylor College of Medicine, Houston, Texas; Mississippi Valley Regional Blood Center, Davenport, Iowa; UBC School of Medicine, Victoria, BC, Canada; AABB, Bethesda, Maryland; Fenwal, Inc., Lake Zurich, Illinois; Regulatory Affairs, AABB, Bethesda, Maryland; and American Red Cross Holland Laboratory, Rockville, Maryland.
    Search for more papers by this author
  • Louis M. Katz,

    1. From the Scientific Support Office, American Red Cross, Gaithersburg, Maryland; Eugene B. Casey Hepatitis Research Center, Baylor College of Medicine, Houston, Texas; Mississippi Valley Regional Blood Center, Davenport, Iowa; UBC School of Medicine, Victoria, BC, Canada; AABB, Bethesda, Maryland; Fenwal, Inc., Lake Zurich, Illinois; Regulatory Affairs, AABB, Bethesda, Maryland; and American Red Cross Holland Laboratory, Rockville, Maryland.
    Search for more papers by this author
  • Steven Kleinman,

    1. From the Scientific Support Office, American Red Cross, Gaithersburg, Maryland; Eugene B. Casey Hepatitis Research Center, Baylor College of Medicine, Houston, Texas; Mississippi Valley Regional Blood Center, Davenport, Iowa; UBC School of Medicine, Victoria, BC, Canada; AABB, Bethesda, Maryland; Fenwal, Inc., Lake Zurich, Illinois; Regulatory Affairs, AABB, Bethesda, Maryland; and American Red Cross Holland Laboratory, Rockville, Maryland.
    Search for more papers by this author
  • Peyton S. Metzel,

    1. From the Scientific Support Office, American Red Cross, Gaithersburg, Maryland; Eugene B. Casey Hepatitis Research Center, Baylor College of Medicine, Houston, Texas; Mississippi Valley Regional Blood Center, Davenport, Iowa; UBC School of Medicine, Victoria, BC, Canada; AABB, Bethesda, Maryland; Fenwal, Inc., Lake Zurich, Illinois; Regulatory Affairs, AABB, Bethesda, Maryland; and American Red Cross Holland Laboratory, Rockville, Maryland.
    Search for more papers by this author
  • Kay R. Gregory,

    1. From the Scientific Support Office, American Red Cross, Gaithersburg, Maryland; Eugene B. Casey Hepatitis Research Center, Baylor College of Medicine, Houston, Texas; Mississippi Valley Regional Blood Center, Davenport, Iowa; UBC School of Medicine, Victoria, BC, Canada; AABB, Bethesda, Maryland; Fenwal, Inc., Lake Zurich, Illinois; Regulatory Affairs, AABB, Bethesda, Maryland; and American Red Cross Holland Laboratory, Rockville, Maryland.
    Search for more papers by this author
  • Roger Y. Dodd

    1. From the Scientific Support Office, American Red Cross, Gaithersburg, Maryland; Eugene B. Casey Hepatitis Research Center, Baylor College of Medicine, Houston, Texas; Mississippi Valley Regional Blood Center, Davenport, Iowa; UBC School of Medicine, Victoria, BC, Canada; AABB, Bethesda, Maryland; Fenwal, Inc., Lake Zurich, Illinois; Regulatory Affairs, AABB, Bethesda, Maryland; and American Red Cross Holland Laboratory, Rockville, Maryland.
    Search for more papers by this author

Susan L. Stramer, PhD, Scientific Support Office, American Red Cross, 9315 Gaither Road, Gaithersburg, MD 20877; e-mail: stramers@usa.redcross.org.

Abstract

BACKGROUND: Emerging infections have been identified as a continuing threat to human health. Many such infections are known to be transmissible by blood transfusion, while others have properties indicating this potential. There has been no comprehensive review of such infectious agents and their threat to transfusion recipient safety to date.

STUDY DESIGN AND METHODS: The members of AABB's Transfusion Transmitted Diseases Committee reviewed a large number of information sources in order to identify infectious agents with actual or potential risk of transfusion transmission now or in the future in the US or Canada; with few exceptions, these agents do not have available interventions to reduce the risk of such transmission. Using a group discussion and writing process, key characteristics of each agent were identified, researched, recorded and documented in standardized format. A group process was used to prioritize each agent on the basis of scientific/epidemiologic data and a subjective assessment of public perception and/or concern expressed by regulatory agencies.

RESULTS: Sixty-eight infectious agents were identified and are described in detail in a single Supplement to TRANSFUSION. Key information will also be provided in web-based form and updated as necessary. The highest priorities were assigned to Babesia species, Dengue virus, and vCJD.

CONCLUSION: The information is expected to support the needs of clinicians and transfusion medicine experts in the recognition and management of emerging infections among blood donors and blood recipients.

Ancillary